FDA’s Loss in LDT Lawsuit Not the Last Word on Enforcement

The FDA’s loss in a district court lawsuit over the final rule for lab-developed tests (LDTs) was a watershed moment in the history of regulation of these tests, although the agency may yet appeal the decision. The outcome of the case, even if it stands, does not eliminate the FDA’s authority to indirectly oversee the…